Formosa Laboratories Acquires SynChem to Expand North American CDMO Footprint

Chemstream and Synthex Organics Announce Strategic Merger

October 26, 2025

Manufacturing

Chemstream announced its merger with Synthex Organics to create a combined specialty chemical solutions platform operating under the Chemstream name. The combined company will integrate Chemstream’s distribution, logistics, and fluid systems expertise with Synthex’s specialty chemical manufacturing and R&D capabilities, expanding technical resources and customer offerings across oil and gas, water treatment, and industrial markets.

Element Materials Technology Acquires Nanosyn

October 11, 2021

Pharmaceuticals

Element Materials Technology acquired Nanosyn, a San Francisco Bay Area-based contract development and manufacturing organization (CDMO) focused on drug discovery and small-batch API manufacturing, to strengthen Element’s pharmaceuticals and biopharmaceutical services in North America. Nanosyn operates three Bay Area facilities and has a team of more than 75 scientists, and the deal expands Element’s end-to-end life sciences capabilities from discovery through clinical development and regulatory support.

Solvias Acquires Chemic Laboratories to Establish U.S. Laboratory Presence

June 17, 2021

Healthcare Services

Solvias has acquired Canton, Massachusetts-based Chemic Laboratories, Inc., giving the Swiss analytical testing and contract research company a U.S. foothold and complementary laboratory testing capabilities. Chemic's co-founders will join Solvias' leadership and continue to run U.S. operations; financial terms were not disclosed.

X-Chem Acquires IntelliSyn and AviSyn to Expand Drug Discovery Services

January 26, 2021

Biotechnology

X-Chem, a portfolio company of GHO Capital, has acquired Montreal-based IntelliSyn and its US-based sister company AviSyn to extend its drug discovery offering into medicinal chemistry, custom synthesis and scale-up process chemistry. The deal integrates downstream hit validation and lead optimisation capabilities into X-Chem’s DNA-Encoded Library (DEL) platform, enabling a streamlined screen-to-lead service for pharma and biotech clients; financial terms were not disclosed.

Aceto Acquires IsleChem to Add U.S. Manufacturing and R&D Capabilities

December 21, 2020

Manufacturing

Aceto U.S., LLC has acquired IsleChem, a Grand Island, New York-based chemical manufacturer and contract R&D provider. The acquisition adds U.S. manufacturing, analytical and R&D capabilities to Aceto’s global specialty-chemicals sourcing and distribution platform and supports expansion of IsleChem’s facility and workforce.

Novacap Acquires PCI Synthesis

June 28, 2018

Pharmaceuticals

Novacap has completed the acquisition of PCI Synthesis, a U.S.-based small-molecule CDMO with R&D and manufacturing sites in Massachusetts. The deal gives Novacap a U.S. footprint and strengthens its global pharmaceutical synthesis and commercial manufacturing capabilities.